WHO Recommends Ervebo Vaccine for Phase 3 Trial in DRC Ebola Outbreak
The World Health Organization has recommended prioritizing the licensed Ebola vaccine Ervebo for a Phase 3 clinical trial in the Democratic Republic of the Congo. This decision follows emerging evidence of cross-protection against the fast-spreading Bundibugyo virus, as the outbreak surges past 4,000 cases and 1,800 deaths. An Unprecedented Outbreak Demands Immediate Intervention The current … Read more